ORTEXORTEX News

Articles

Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.

Trader Note — 14847 total

Trader NoteREGN

Analysts Lift Targets as REGN Approaches October Earnings

Regeneron Pharmaceuticals heads into its October 30 Q3 print with a busy week of analyst target upgrades sitting against a stock that is still down 11% over the past month. The Street's direction of travel is unusually…

1 min read
Trader NoteRPM

RPM Earnings Week: Put Fever Breaks, Now Comes the Verdict

RPM International delivered its October 8 print into the most defensively positioned options market it has seen in over a year, and the question now is whether that hedging was well-placed or simply noise ahead of a…

1 min read
Trader NoteQCOM

QCOM Shorts Rebuild as CEO Sells Into Strength

QUALCOMM enters its November earnings cycle with an awkward combination: short interest has built sharply over the past month, the CEO has been selling at prices well above the current level, and the Street holds a…

1 min read
Trader NoteCOP

Analysts Lift COP Targets as Shorts Continue to Fade

ConocoPhillips enters the final stretch before its November 5 earnings with analysts raising targets, short sellers continuing to exit, and the stock up 3% on the week, a tighter, cleaner setup than the one described…

1 min read
Trader NotePFE

Pfizer Drifts Lower with Earnings 20 Days Out

PFE heads into its October 27 quarterly print having lost 4.2% on the week, trading at $27.50, with the insider buying cluster documented a week ago still the clearest signal of conviction around the stock. The analyst…

1 min read
Trader NoteRVTY

Revvity shorts rebuild as Barclays lifts target to $160

RVTY enters the final stretch before its November 3 earnings with a stock up 18% in a month, short sellers quietly adding to positions, and the Street split on whether the rally has outrun the fundamentals. The most…

1 min read
Trader NoteORCL

Oracle Claws Back 5% but Bears Keep One Hand on the Wheel

ORCL has recovered 5% this week to $144.77, yet the stock remains down roughly 25% year-to-date, leaving the week's bounce looking more like a pause than a reversal. The short-side picture has quietly shifted since the…

1 min read